HomeCompareHRPMF vs NNN

HRPMF vs NNN: Dividend Comparison 2026

HRPMF yields 56.98% · NNN yields 5.68%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 HRPMF wins by $535.7K in total portfolio value
10 years
HRPMF
HRPMF
● Live price
56.98%
Share price
$3.51
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$561.2K
Annual income
$126,052.94
Full HRPMF calculator →
NNN
NNN REIT Inc.
● Live price
5.68%
Share price
$41.89
Annual div
$2.38
5Y div CAGR
8.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.6K
Annual income
$2,637.42
Full NNN calculator →

Portfolio growth — HRPMF vs NNN

📍 HRPMF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHRPMFNNN
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HRPMF + NNN cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HRPMF pays
NNN pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HRPMF
Annual income on $10K today (after 15% tax)
$4,843.30/yr
After 10yr DRIP, annual income (after tax)
$107,145.00/yr
NNN
Annual income on $10K today (after 15% tax)
$482.93/yr
After 10yr DRIP, annual income (after tax)
$2,241.81/yr
At 15% tax rate, HRPMF beats the other by $104,903.19/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HRPMF + NNN for your $10,000?

HRPMF: 50%NNN: 50%
100% NNN50/50100% HRPMF
Portfolio after 10yr
$293.4K
Annual income
$64,345.18/yr
Blended yield
21.93%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on NNN right now

HRPMF
No analyst data
Altman Z
-40.5
Piotroski
2/9
NNN
Analyst Ratings
10
Buy
15
Hold
4
Sell
Consensus: Hold
Price Target
$44.93
+7.3% upside vs current
Range: $43.00 — $48.50
Altman Z
1.1
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HRPMF buys
0
NNN buys
0
No recent congressional trades found for HRPMF or NNN in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHRPMFNNN
Forward yield56.98%5.68%
Annual dividend / share$2.00$2.38
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%8.6%
Portfolio after 10y$561.2K$25.6K
Annual income after 10y$126,052.94$2,637.42
Total dividends collected$460.7K$13.7K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: HRPMF vs NNN ($10,000, DRIP)

YearHRPMF PortfolioHRPMF Income/yrNNN PortfolioNNN Income/yrGap
1← crossover$16,398$5,698.01$10,737$617.02+$5.7KHRPMF
2$26,278$8,732.33$11,577$710.93+$14.7KHRPMF
3$41,196$13,078.29$12,538$822.59+$28.7KHRPMF
4$63,241$19,161.35$13,645$956.06+$49.6KHRPMF
5$95,159$27,490.76$14,925$1,116.51+$80.2KHRPMF
6$140,479$38,659.15$16,415$1,310.57+$124.1KHRPMF
7$203,650$53,337.34$18,158$1,546.77+$185.5KHRPMF
8$290,169$72,263.73$20,213$1,836.20+$270.0KHRPMF
9$406,709$96,228.48$22,649$2,193.37+$384.1KHRPMF
10$561,232$126,052.94$25,558$2,637.42+$535.7KHRPMF

HRPMF vs NNN: Complete Analysis 2026

HRPMFStock

Herantis Pharma Oyj, a biotech company, engages in the development of disease-modifying CDNF-based therapies for Parkinson's disease (PD). Its lead product in pipeline includes HER-096, an advanced small and synthetic chemical peptidomimetic version of the active parent as the preclinical xCDNF candidate for the treatment of PD and other neurodegenerative diseases; and recombinant human Cerebral Dopamine Neurotrophic Factor (rhCDNF), a biological protein that is in Phase I study in patients with PD. The company was incorporated in 2008 and is based in Espoo, Finland.

Full HRPMF Calculator →

NNNREIT

National Retail Properties invests primarily in high-quality retail properties subject generally to long-term, net leases. As of September 30, 2020, the company owned 3,114 properties in 48 states with a gross leasable area of approximately 32.4 million square feet and with a weighted average remaining lease term of 10.7 years.

Full NNN Calculator →
📬

Get this HRPMF vs NNN comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HRPMF vs SCHDHRPMF vs JEPIHRPMF vs OHRPMF vs KOHRPMF vs MAINHRPMF vs ADCHRPMF vs EPRTHRPMF vs FCPT

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.